SHAREHOLDER ALERT: The Law Offices of Timothy L. Miles Informs Investors of a Lawsuit Against Kiromic BioPharma, Inc.

Class action lawsuit charges Kiromic BioPharma and certain of its top executive officers with violations of the Securities Exchange Act of 1933 & 1934.

Related Keywords

Tennessee ,United States ,America ,Kiromic Biopharma ,Kiromic Biopharma Inc ,Linkedin ,Twitter ,National Trial Lawyers Association ,Drug Administration ,Nasdaq ,Securities Exchange ,Facebook ,Free Portfolio Monitoring Services ,Law Offices ,Securities Exchange Act ,Biopharma Are Urged ,Additional Information ,Securities Act ,Kiromic Biopharma Class Action ,Investigational New Drug ,Offering Documents ,Biopharma Shareholders Urged ,Ranked Lawyer ,Plaintiff Trial Lawyers ,Lifetime Achievement Award ,Premier Lawyers ,Distinguished Lawyer ,Recognizing Excellence ,Securities Law ,Top Rated Litigator ,Top Rated Lawyer ,Ethical Standards ,Legal Ability ,Superb Rated Attorney ,Avvo Top Rated Lawyer ,Free Portfolio Monitoring Services Offered ,Visit Us Here ,Click Here ,Timothyl Miles ,